CDDO-dhTFEA, CAS [[1191265-33-4]]

Produktübersicht

• Artikelname: CDDO-dhTFEA, CAS [[1191265-33-4]]
• Artikelnummer: MCE-HY-112671
• Hersteller Artikelnummer: HY-112671
• Alternativnummer: MCE-HY-112671-5MG,MCE-HY-112671-50MG,MCE-HY-112671-100MG,MCE-HY-112671-10MMX1ML,MCE-HY-112671-10MG,MCE-HY-112671-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: RTA dh404

Produktbeschreibung

CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-kappaB[1]. CDDO-dhTFEA restores hypertension (MAP), increases Nrf2 and expression of its target genes, attenuates activation of NF-kappaB and transforming growth factor-beta pathways, and reduces glomerulosclerosis, interstitial fibrosis and inflammation in the chronic kidney disease (CKD) rats[2].

Produkteigenschaften

• Molekulargewicht: 574.72
• Reinheit: 99.64
• CAS Nummer: [1191265-33-4]
• Formel: C33H45F3N2O3
• Target-Kategorie: Apoptosis,Keap1-Nrf2,NF-kappaB

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound